Advertisement

Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)

Published:January 27, 2020DOI:https://doi.org/10.1016/j.dld.2019.12.008

      Abstract

      Alcohol use disorder which includes alcohol abuse and dependence represents one of the leading risk factors for premature mortality in Europe and it is responsible of over 200 conditions, including neuropsychiatric disorders, chronic diseases, cancers and accidents leading to permanent disability. Alcohol use disorder represents the most common cause of liver damage in the Western world, with a wide spectrum of diseases ranging from steatosis, steatohepatitis, fibrosis, cirrhosis and cancer. The present clinical practice guidelines by the Italian Association for the Study of the Liver (AISF) are focused on the current knowledge about epidemiology, pathophysiology, clinical features, diagnosis and treatment of alcohol associated liver disease, aiming to provide practical recommendations on the management of this complex pathological condition.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rehm J.
        • Mathers C.
        • Popova S.
        • Thavorncharoensap M.
        • Teerawattananon Y.
        • Patra J.
        Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.
        Lancet. 2009; 373: 2223-2233
        • Forouzanfar M.H.
        • Alexander L.
        • Anderson H.R.
        • Bachman V.F.
        • Biryukov S.
        • Brauer M.
        • et al.
        Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.
        Lancet. 2015; 386: 2287-2323
        • Baan R.
        • Straif K.
        • Grosse Y.
        • Secretan B.
        • El Ghissassi F.
        • Bouvard V.
        • et al.
        Carcinogenicity of alcoholic beverages.
        Lancet Oncol. 2007; 8: 292-293
        • Shield K.D.
        • Parry C.
        • Rehm J.
        Chronic diseases and conditions related to alcohol use.
        Alcohol Res. 2013; 35: 155-173
        • Stewart B.W.
        • Wild C.P.
        • International Agency for Research on Cancer
        • et al.
        World cancer report.
        2014
      1. World Health Organization, Geneva. Switzerland Global status report on alcohol and health; 2014.

      2. World Health Organization, Geneva. Switzerland Global status report on alcohol and health; 2018.

        • Grüne B.
        • Piontek D.
        • Sleczka P.
        • Kraus L.
        • Pogarell O.
        Drinking location and drinking culture and their association with alcohol use among girls and boys in Europe.
        J Stud Alcohol Drugs. 2017; 78: 549-557
        • Kuntsche E.
        • Knibbe R.
        • Gmel G.
        • Engels R.
        “I drink spirits to get drunk and block out my problems…” beverage preference, drinking motives and alcohol use in adolescence.
        Alcohol Alcohol. 2006; 41: 566-573
        • Stern S.A.
        • Terry-McElrath Y.M.
        • Patrick M.E.
        Beverage-specific patterns of 5+ alcoholic drink consumption by young adults in the U.S.
        Addict Behav. 2017; 65: 19-24
        • WHO Collaborating Centre for Research on Alcohol – Italian National Observatory for Alcohol
        Epidemiology and monitoring of alcohol use in Italy and in the regions – report.
        2018
      3. Adolescent alcohol-related behaviours: trends and inequalities in the WHO European Region, 2002–2014 (2018) 2018.

        • Istisan R.
        • Scafato E.
        • Gandin C.
        • Galluzzo R.
        • Scipione M.
        • Vichi S.
        • et al.
        Epidemiologia e monitoraggio alcol-correlato in Italia e nelle Regioni Valutazione dell’Osservatorio Nazionale Alcol-CNESPS sull’impatto del consumo di alcol ai fini dell’implementazione delle attività del Piano Nazionale Alcol e Salute Rapporto.
        2017 (n.d)
      4. National Institute on Alcohol Abuse and Alcoholism (NIAAA) “Dietary Guidelines for Americans 2015–2020”, U.S. Department of Health and Human Services and U.S. Department of Agriculture.

      5. World Health Organization, Geneva. Switzerland Global Information System on Alcohol and Health (GISAH); 2018.

        • Xi B.
        • Veeranki S.P.
        • Zhao M.
        • Ma C.
        • Yan Y.
        • Mi J.
        Relationship of alcohol consumption to all-cause, cardiovascular, and cancer-related mortality in U.S. adults.
        J Am Coll Cardiol. 2017; 70: 913-922
        • GBD 2016 Alcohol Collaborators
        Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.
        Lancet. 2018; 392: 1015-1035
        • Fillmore M.T.
        • Jude R.
        Defining “binge” drinking as five drinks per occasion or drinking to a .08% BAC: which is more sensitive to risk?.
        Am J Addict. 2011; 20: 468-475
        • Addolorato G.
        • Vassallo G.A.
        • Antonelli G.
        • Antonelli M.
        • Tarli C.
        • Mirijello A.
        • et al.
        Binge Drinking among adolescents is related to the development of alcohol use disorders: results from a cross-sectional study.
        Sci Rep. 2018; 8: 12624
        • Cederbaum A.I.
        Alcohol metabolism.
        Clin Liver Dis. 2012; 16: 667-685
        • Åberg F.
        • Helenius-Hietala J.
        • Puukka P.
        • Jula A.
        Binge drinking and the risk of liver events: a population-based cohort study.
        Liver Int. 2017; 37: 1373-1381
        • Bala S.
        • Marcos M.
        • Gattu A.
        • Catalano D.
        • Szabo G.
        Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.
        PLoS One. 2014; 9e96864
        • Nygren K.
        • Hammarström A.
        • Rolandsson O.
        Binge drinking and total alcohol consumption from 16 to 43 years of age are associated with elevated fasting plasma glucose in women: results from the northern Swedish cohort study.
        BMC Public Health. 2017; 17: 509
        • Yin H.-Q.
        • Kim M.
        • Kim J.-H.
        • Kong G.
        • Kang K.S.
        • Kim H.L.
        • et al.
        Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice.
        Toxicol Appl Pharmacol. 2007; 223: 225-233
        • Afshar M.
        • Richards S.
        • Mann D.
        • Cross A.
        • Smith G.B.
        • Netzer G.
        • et al.
        Acute immunomodulatory effects of binge alcohol ingestion.
        Alcohol. 2015; 49: 57-64
        • Crews F.T.
        • Vetreno R.P.
        • Broadwater M.A.
        • Robinson D.L.
        Adolescent alcohol exposure persistently impacts adult neurobiology and behavior.
        Pharmacol Rev. 2016; 68: 1074-1109
        • Llerena S.
        • Arias-Loste M.T.
        • Puente A.
        • Cabezas J.
        • Crespo J.
        • Fábrega E.
        Binge drinking: burden of liver disease and beyond.
        World J Hepatol. 2015; 7: 2703-2715
        • Sundell L.
        • Salomaa V.
        • Vartiainen E.
        • Poikolainen K.
        • Laatikainen T.
        Increased stroke risk is related to a binge drinking habit.
        Stroke. 2008; 39: 3179-3184
        • Georgie J.M.
        • Sean H.
        • Deborah M.C.
        • Matthew H.
        • Rona C.
        Peer-led interventions to prevent tobacco, alcohol and/or drug use among young people aged 11–21 years: a systematic review and meta-analysis.
        Addiction. 2016; 111: 391-407
        • Kandi S.
        • Deshpande N.
        • Bharath Kumar Pinnelli V.
        • Devaki R.
        • Rao P.
        • Ramana K.V.
        Alcoholism and its role in the development of oxidative stress and DNA damage: an insight.
        Am J Med Sci Med. 2014; 2: 64-66
        • Thakur V.
        • Pritchard M.T.
        • McMullen M.R.
        • Wang Q.
        • Nagy L.E.
        Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-production.
        J Leukoc Biol. 2006; 79: 1348-1356
        • Yin H.
        • Xu L.
        • Porter N.A.
        Free radical lipid peroxidation: mechanisms and analysis.
        Chem Rev. 2011; 111: 5944-5972
        • Ayala A.
        • Munoz M.F.
        • Argüelles S.
        Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-Nonenal.
        Oxid Med Cell Longev. 2014; 2014: 1-31
        • Comporti M.
        • Signorini C.
        • Leoncini S.
        • Gardi C.
        • Ciccoli L.
        • Giardini A.
        • et al.
        Ethanol-induced oxidative stress: basic knowledge.
        Genes Nutr. 2010; 5: 101-109
        • Portari G.V.
        • Ovidio P.P.
        • Deminice R.
        • Jordão Jr., A.A.
        Protective effect of treatment with thiamine or benfotiamine on liver oxidative damage in rat model of acute ethanol intoxication.
        Life Sci. 2016; 162: 21-24
        • Ji C.
        Advances and new concepts in alcohol-induced organelle stress, unfolded protein responses and organ damage.
        Biomolecules. 2015; 5: 1099-1121
        • Daniele T.
        • Schiaffino M.V.
        Organelle biogenesis and interorganellar connections.
        Commun Integr Biol. 2014; 7e29587
        • Ji C.
        • Kaplowitz N.
        Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice.
        Gastroenterology. 2003; 124: 1488-1499
        • Romero A.M.
        • Renau-Piqueras J.
        • Marín M.P.
        • Esteban-Pretel G.
        Chronic alcohol exposure affects the cell components involved in membrane traffic in neuronal dendrites.
        Neurotox Res. 2015; 27: 43-54
        • Taniguchi M.
        • Nadanaka S.
        • Tanakura S.
        • Sawaguchi S.
        • Midori S.
        • Kawai Y.
        • et al.
        TFE3 is a bHLH-ZIP-type transcription factor that regulates the mammalian golgi stress response.
        Cell Struct Funct. 2015; 40: 13-30
        • Li T.
        • You H.
        • Mo X.
        • He W.
        • Tang X.
        • Jiang Z.
        • et al.
        GOLPH3 mediated golgi stress response in modulating N2A cell death upon oxygen-glucose deprivation and reoxygenation injury.
        Mol Neurobiol. 2016; 53: 1377-1385
        • Vary T.C.
        • Lynch C.J.
        • Lang C.H.
        Effects of chronic alcohol consumption on regulation of myocardial protein synthesis.
        2001
        • McClintick J.N.
        • Xuei X.
        • Tischfield J.A.
        • Goate A.
        • Foroud T.
        • Wetherill L.
        • et al.
        Stress-response pathways are altered in the hippocampus of chronic alcoholics.
        Alcohol. 2013; 47: 505-515
        • Natarajan S.K.
        • Pachunka J.M.
        • Mott J.L.
        Role of microRNAs in alcohol-induced multi-organ injury.
        Biomolecules. 2015; 5: 3309-3338
        • Yeligar S.
        • Tsukamoto H.
        • Kalra V.K.
        Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1 and microRNA-199.
        J Immunol. 2009; 183: 5232-5243
        • Chen W.
        • Han C.
        • Zhang J.
        • Song K.
        • Wang Y.
        • Wu T.
        • et al.
        Deletion of Mir155 prevents fas-induced liver injury through up-regulation of Mcl-1.
        Am J Pathol. 2015; 185: 1033-1044
        • Yin H.
        • Hu M.
        • Zhang R.
        • Shen Z.
        • Flatow L.
        • You M.
        MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1.
        J Biol Chem. 2012; 287: 9817-9826
        • Lewohl J.M.
        • Nunez Y.O.
        • Dodd P.R.
        • Tiwari G.R.
        • Harris R.A.
        • Mayfield R.D.
        Up-regulation of MicroRNAs in brain of human alcoholics.
        Alcohol Clin Exp Res. 2011; 35: 1928-1937
        • Yadav S.
        • Pandey A.
        • Shukla A.
        • Talwelkar S.S.
        • Kumar A.
        • Pant A.B.
        • et al.
        miR-497 and miR-302b regulate ethanol induced neuronal cell death through BCL2 protein and cyclin D2.
        J Biol Chem. 2011; 286: 37347-37357
        • Charrier A.
        • Chen R.
        • Chen L.
        • Kemper S.
        • Hattori T.
        • Takigawa M.
        • et al.
        Connective tissue growth factor (CCN2) and microRNA-21 are components of a positive feedback loop in pancreatic stellate cells (PSC) during chronic pancreatitis and are exported in PSC-derived exosomes.
        J Cell Commun Signal. 2014; 8: 147-156
        • Charrier A.L.
        • Brigstock D.R.
        Connective tissue growth factor production by activated pancreatic stellate cells in mouse alcoholic chronic pancreatitis.
        Lab Invest. 2010; 90: 1179-1188
        • Xie Z.
        • Klionsky D.J.
        Autophagosome formation: core machinery and adaptations.
        Nat Cell Biol. 2007; 9: 1102-1109
        • Li Y.
        • Wang S.
        • Ni H.-M.
        • Huang H.
        • Ding W.X.
        • et al.
        Autophagy in alcohol-induced multiorgan injury: mechanisms and potential therapeutic targets.
        Biomed Res Int. 2014; 2014498491
        • O’Shea R.S.
        • Dasarathy S.
        • McCullough A.J.
        • Practice guideline committee of the american association for the study of liver diseases; practice parameters committee of the american college of gastroenterology
        Alcoholic liver disease.
        Hepatology. 2010; 51: 307-328
        • Kourkoumpetis T.
        • Sood G.
        Pathogenesis of alcoholic liver disease.
        Clin Liver Dis. 2019; 23: 71-80
        • Baraona E.
        • Lieber C.S.
        Effects of ethanol on lipid metabolism.
        J Lipid Res. 1979; 20: 289-315
        • Sozio M.
        • Liangpunsakul S.
        • Crabb D.
        The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.
        Semin Liver Dis. 2010; 30: 378-390
        • Sargent S.
        The aetiology, management and complications of alcoholic hepatitis.
        Br J Nurs. 2005; 14: 556-562
        • Yu S.
        • Rao S.
        • Reddy J.K.
        Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis.
        Curr Mol Med. 2003; 3: 561-572
        • Gao B.
        • Ahmad M.F.
        • Nagy L.E.
        • Tsukamoto H.
        Inflammatory pathways in alcoholic steatohepatitis.
        J Hepatol. 2019; 70: 249-259
        • Lazaro R.
        • Wu R.
        • Lee S.
        • Zhu N.L.
        • Chen C.L.
        • French S.W.
        • et al.
        Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice.
        Hepatology. 2015; 61: 129-140
        • Li M.
        • He Y.
        • Zhou Z.
        • Ramirez T.
        • Gao Y.
        • Gao Y.
        • et al.
        MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47 phox-oxidative stress pathway in neutrophils.
        Gut. 2017; 66: 705-715
        • Altamirano J.
        • Miquel R.
        • Katoonizadeh A.
        • Abraldes J.G.
        • Duarte-Rojo A.
        • Louvet A.
        • et al.
        A histologic scoring system for prognosis of patients with alcoholic hepatitis.
        Gastroenterology. 2014; 146 (1231–9.e6)
        • Dominguez M.
        • Miquel R.
        • Colmenero J.
        • Moreno M.
        • García-Pagán J.C.
        • Bosch J.
        • et al.
        Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.
        Gastroenterology. 2009; 136: 1639-1650
        • Wang W.
        • Xu M.-J.
        • Cai Y.
        • Zhou Z.
        • Cao H.
        • Mukhopadhyay P.
        • et al.
        Inflammation is independent of steatosis in a murine model of steatohepatitis.
        Hepatology. 2017; 66: 108-123
        • Rajkovic I.A.
        • Williams R.
        Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis.
        Hepatology. 1986; 6: 252-262
        • Li W.
        • Amet T.
        • Xing Y.
        • Yang D.
        • Liangpunsakul S.
        • Puri P.
        • et al.
        Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: a prospective observational study.
        Hepatology. 2017; 66: 575-590
        • Liaskou E.
        • Henriksen E.K.K.
        • Holm K.
        • Kaveh F.
        • Hamm D.
        • Fear J.
        • et al.
        High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires.
        Hepatology. 2016; 63: 1608-1619
        • Markwick L.J.L.
        • Riva A.
        • Ryan J.M.
        • Cooksley H.
        • Palma E.
        • Tranah T.H.
        • et al.
        Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.
        Gastroenterology. 2015; 148: 590-602.e10
        • Pritchard M.T.
        • McMullen M.R.
        • Stavitsky A.B.
        • Cohen J.I.
        • Lin F.
        • Edward Medof M.
        • et al.
        Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.
        Gastroenterology. 2007; 132: 1117-1126
        • Nagy L.E.
        The role of innate immunity in alcoholic liver disease.
        Alcohol Res. 2015; 37: 237-250
        • Xu J.
        • Chi F.
        • Guo T.
        • Punj V.
        • Lee W.N.
        • French S.W.
        • et al.
        NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation.
        J Clin Invest. 2015; 125: 1579-1590
        • Xu M.-J.
        • Zhou Z.
        • Parker R.
        • Gao B.
        Targeting inflammation for the treatment of alcoholic liver disease.
        Pharmacol Ther. 2017; 180: 77-89
        • Affò S.
        • Morales-Ibanez O.
        • Rodrigo-Torres D.
        • Altamirano J.
        • Blaya D.
        • Dapito D.H.
        • et al.
        CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis.
        Gut. 2014; 63: 1782-1792
        • Hartmann P.
        • Seebauer C.T.
        • Schnabl B.
        Alcoholic liver disease: the gut microbiome and liver cross talk.
        Alcohol Clin Exp Res. 2015; 39: 763-775
        • Rao R.
        Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
        Hepatology. 2009; 50: 638-644
        • Tripathi A.
        • Debelius J.
        • Brenner D.A.
        • Karin M.
        • Loomba R.
        • Schnabl B.
        • et al.
        The gut–liver axis and the intersection with the microbiome.
        Nat Rev Gastroenterol Hepatol. 2018; 15: 397-411
        • Yang A.-M.
        • Inamine T.
        • Hochrath K.
        • Chen P.
        • Wang L.
        • Llorente C.
        • et al.
        Intestinal fungi contribute to development of alcoholic liver disease.
        J Clin Invest. 2017; 127: 2829-2841
        • Brenner C.
        • Galluzzi L.
        • Kepp O.
        • Kroemer G.
        Decoding cell death signals in liver inflammation.
        J Hepatol. 2013; 59: 583-594
        • Steiner J.
        • Lang C.
        Alcohol, adipose tissue and lipid dysregulation.
        Biomolecules. 2017; 7: 16
        • Gao X.
        • Salomon C.
        • Freeman D.J.
        Extracellular vesicles from adipose tissue—a potential role in obesity and type 2 diabetes?.
        Front Endocrinol (Lausanne). 2017; 8: 202
        • Witek R.P.
        • Yang L.
        • Liu R.
        • Jung Y.
        • Omenetti A.
        • Syn W.K.
        • et al.
        Liver cell–derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells.
        Gastroenterology. 2009; 136 (320–30.e2)
        • Inokuchi S.
        • Tsukamoto H.
        • Park E.
        • Liu Z.X.
        • Brenner D.A.
        • Seki E.
        Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.
        Alcohol Clin Exp Res. 2011; 35 (no–no)
        • Gao B.
        • Bataller R.
        Alcoholic liver disease: pathogenesis and new therapeutic targets.
        Gastroenterology. 2011; 141: 1572-1585
        • MacSween R.
        • Burt A.
        Histologic Spectrum of alcoholic liver disease.
        Semin Liver Dis. 1986; 6: 221-232
        • Morgan T.R.
        • Ghany M.G.
        • Kim H.-Y.
        • Snow K.K.
        • Shiffman M.L.
        • De Santo J.L.
        • et al.
        Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
        Hepatology. 2010; 52: 833-844
        • Rolando N.
        • Philpott-Howard J.
        • Williams R.
        Bacterial and fungal infection in acute liver failure.
        Semin Liver Dis. 1996; 16: 389-402
        • Nojkov B.
        • Cappell M.S.
        Distinctive aspects of peptic ulcer disease, Dieulafoy’s lesion, and Mallory–Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis.
        World J Gastroenterol. 2016; 22: 446
        • Fiellin D.A.
        • Kleber H.
        • Trumble-Hejduk J.G.
        • McLellan A.T.
        • Kosten T.R.
        Consensus statement on office-based treatment of opioid dependence using buprenorphine.
        J Subst Abuse Treat. 2004; 27: 153-159
        • Sullivan J.T.
        • Sykora K.
        • Schneiderman J.
        • Naranjo C.A.
        • Sellers E.M.
        Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA- 1615 Ar).
        Br J Addict. 1989; 84: 1353-1357
        • Caputo F.
        • Domenicali M.
        • Bernardi M.
        Diagnosis and treatment of alcohol use disorder in patients with end-stage alcoholic liver disease.
        Hepatology. 2019; 70: 410-417
        • Jepsen P.
        • Ott P.
        • Andersen P.K.
        • Sørensen H.T.
        • Vilstrup H.
        Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.
        Hepatology. 2010; 51: 1675-1682
        • Wiegand J.
        • Kühne M.
        • Pradat P.
        • Mössner J.
        • Trepo C.
        • Tillmann H.L.
        Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
        Aliment Pharmacol Ther. 2012; 35: 1443-1450
        • Le Moine O.
        • Hadengue A.
        • Moreau R.
        • Sogni P.
        • Soupison T.
        • Yang S.
        • et al.
        Relationship between portal pressure, esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis.
        Scand J Gastroenterol. 1997; 32: 731-735
        • Bell H.
        • Jahnsen J.
        • Kittang E.
        • Raknerud N.
        • Sandvik L.
        Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit.
        Scand J Gastroenterol. 2004; 39: 858-863
        • Bolognesi M.
        • Verardo A.
        • Di Pascoli M.
        Peculiar characteristics of portal-hepatic hemodynamics of alcoholic cirrhosis.
        World J Gastroenterol. 2014; 20: 8005
        • Luca A.
        • Garcia J.C.
        • Garcia-Pagan G.
        • Feu F.
        • Caballería J.
        • Groszmann R.J.
        • et al.
        Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis.
        Gastroenterology. 1997; 112: 1284-1289
        • Sargenti K.
        • Prytz H.
        • Nilsson E.
        • Bertilsson S.
        • Kalaitzakis E.
        Bacterial infections in alcoholic and nonalcoholic liver cirrhosis.
        Eur J Gastroenterol Hepatol. 2015; 27: 1080-1086
        • Gustot T.
        • Fernandez J.
        • Szabo G.
        • Albillos A.
        • Louvet A.
        • Jalan R.
        • et al.
        Sepsis in alcohol-related liver disease.
        J Hepatol. 2017; 67: 1031-1050
        • Dasarathy S.
        Nutrition and alcoholic liver disease: effects of alcoholism on nutrition, effects of nutrition on alcoholic liver disease, and nutritional therapies for alcoholic liver disease.
        Clin Liver Dis. 2016; 20: 535-550
        • Bourdon K.H.
        • Rae D.S.
        • Locke B.Z.
        • Narrow W.E.
        • Regier D.A.
        Estimating the prevalence of mental disorders in U.S. adults from the Epidemiologic Catchment Area Survey.
        Public Health Rep. 1992; 107: 663-668
        • Glass J.E.
        • Williams E.C.
        • Bucholz K.K.
        Psychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder.
        Alcohol Clin Exp Res. 2014; 38: 1697-1705
        • Altamirano J.
        • Bataller R.
        Cigarette smoking and chronic liver diseases.
        Gut. 2010; 59: 1159-1162
        • Chandrakumar A.
        • Bhardwaj A.
        • ‘t Jong G.W.
        Review of thiamine deficiency disorders: Wernicke encephalopathy and Korsakoff psychosis.
        J Basic Clin Physiol Pharmacol. 2018; (0)
        • Thomson A.D.
        • Cook C.C.
        • Guerrini I.
        • Sheedy D.
        • Harper C.
        • Marshall E.J.
        • et al.
        Wernicke’s encephalopathy revisited. Translation of the case history section of the original manuscript by Carl Wernicke’Lehrbuch der Gehirnkrankheiten fur Aerzte and Studirende’ (1881) with a commentary.
        Alcohol Alcohol. 2008; 43: 174-179
        • Shiozawa T.
        • Shiota H.
        • Shikata E.
        • Kamei S.
        • Mizutani T.
        Development of Wernicke’s encephalopathy during the period of oral food intake after a subtotal colectomy for ulcerative colitis.
        Rinsho Shinkeigaku. 1995; 35: 169-174
        • Harper C.G.
        • Giles M.
        • Finlay-Jones R.
        Clinical signs in the Wernicke–Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy.
        J Neurol Neurosurg Psychiatry. 1986; 49: 341-345
        • Jung Y.-C.
        • Chanraud S.
        • Sullivan E.V.
        Neuroimaging of Wernicke’s encephalopathy and Korsakoff’s syndrome.
        Neuropsychol Rev. 2012; 22: 170-180
        • Koike H.
        • Iijima M.
        • Sugiura M.
        • Mori K.
        • Hattori N.
        • Ito H.
        • et al.
        Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy.
        Ann Neurol. 2003; 54: 19-29
        • Ravaglia S.
        • Marchioni E.
        • Costa A.
        • Maurelli M.
        • Moglia A.
        Erectile dysfunction as a sentinel symptom of cardiovascular autonomic neuropathy in heavy drinkers.
        J Peripher Nerv Syst. 2004; 9: 209-214
        • Vittadini G.
        • Buonocore M.
        • Colli G.
        • Terzi M.
        • Fonte R.
        • Biscaldi G.
        Alcoholic polyneuropathy: a clinical and epidemiological study.
        Alcohol Alcohol. 2001; 36: 393-400
        • Zambelis T.
        • Karandreas N.
        • Tzavellas E.
        • Kokotis P.
        • Liappas J.
        Large and small fiber neuropathy in chronic alcohol-dependent subjects.
        J Peripher Nerv Syst. 2005; 10: 375-381
        • D’Amour M.L.
        • Shahani B.T.
        • Young R.R.
        • Bird K.T.
        The importance of studying sural nerve conduction and late responses in the evaluation of alcoholic subjects.
        Neurology. 1979; 29: 1600-1604
        • Mills K.R.
        • Ward K.
        • Martin F.
        • Peters T.J.
        Peripheral neuropathy and myopathy in chronic alcoholism.
        Alcohol Alcohol. 1986; 21: 357-362
        • Yoshii F.
        • Kobakake K.
        • Shinohara Y.
        • Takagi S.
        Neurological manifestations in chronic alcoholics.
        Tokai J Exp Clin Med. 1985; 10: 615-620
        • Fauchier L.
        • Babuty D.
        • Poret P.
        • Casset-Senon D.
        • Autret M.L.
        • Cosnay P.
        • et al.
        Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy.
        Eur Heart J. 2000; 21: 306-314
        • Guzzo-Merello G.
        • Cobo-Marcos M.
        • Gallego-Delgado M.
        • Garcia-Pavia P.
        Alcoholic cardiomyopathy.
        World J Cardiol. 2014; 6: 771
        • Li X.
        • Nie Y.
        • Lian H.
        • Hu S.
        Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy.
        Medicine (Baltimore). 2018; 97e12259
        • Scafato E.
        • Ghirini S.
        • Galluzzo L.
        • Gandin C.
        The implementation in Europe (EU) of the low risk drinking guidelines: results from the RARHA survey.
        Addict Sci Clin Pract. 2015; 10: P17
      6. DHHS, DoA. 2015-2020Dietary Guidelines for Americans. In: 8th ed. Available on: http://health.gov/dietaryguidelines/2015/.

        • Saunders J.B.
        • Aasland O.G.
        • Babor T.F.
        • de la Fuente J.R.
        • Grant M.
        Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption—II.
        Addiction. 1993; 88: 791-804
        • Bush K.
        • Kivlahan D.R.
        • McDonell M.B.
        • Fihn S.D.
        • Bradley K.A.
        The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol use disorders identification test.
        Arch Intern Med. 1998; 158: 1789-1795
      7. National Institute on Alcohol Abuse and Alcoholism. Alcohol screening and brief intervention for youth: a practitioner’s guide. Available at: www.niaaa.nih.gov/YouthGuide. [Accessed 1 December 2011].

        • Kelly S.M.
        • Gryczynski J.
        • Mitchell S.G.
        • Kirk A.
        • O'Grady K.E.
        • Schwartz R.P.
        Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use.
        Pediatrics. 2014; 133: 819-826
        • Barnes A.J.
        • Moore A.A.
        • Xu H.
        • Ang A.
        • Tallen L.
        • Mirkin M.
        • et al.
        Prevalence and correlates of at-risk drinking among older adults: the project SHARE study.
        J Gen Intern Med. 2010; 25: 840-846
        • O’Brien P.L.
        Performance measurement: a proposal to increase use of screening, brief intervention, and referral to treatment (SBIRT) and decrease alcohol consumption during pregnancy.
        Matern Child Health J. 2014; 18: 1-9
        • World Health Organization Working Group
        The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility.
        Addiction. 2002; 97: 1183-1184
        • European Association for the Study of Liver
        EASL clinical practical guidelines: management of alcohol-related liver disease.
        J Hepatol. 2018; 69: 154-181
        • Singal A.K.
        • Bataller R.
        • Ahn J.
        • Kamath P.S.
        • Shah V.H.
        ACG clinical guideline: alcoholic liver disease.
        Am J Gastroenterol. 2018; 113: 175-194
        • Alte D.
        • Luedemann J.
        • Rose H.-J.
        • John U.
        Laboratory markers carbohydrate deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the study of health in Pomerania (SHIP).
        Alcohol Clin Exp Res. 2004; 28: 931-940
        • Zatloukal K.
        • French S.W.
        • Stumptner C.
        • Strnad P.
        • Harada M.
        • Toivola D.M.
        • et al.
        From Mallory to Mallory–Denk bodies: what, how and why?.
        Exp Cell Res. 2007; 313: 2033-2049
        • Lefkowitch J.H.
        Morphology of alcoholic liver disease.
        Clin Liver Dis. 2005; 9: 37-53
        • Fromenty B.
        • Grimbert S.
        • Mansouri A.
        • Beaugrand M.
        • Erlinger S.
        • Rötig A.
        • et al.
        Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis.
        Gastroenterology. 1995; 108: 193-200
        • Lackner C.
        • Gogg-Kamerer M.
        • Zatloukal K.
        • Stumptner C.
        • Brunt E.M.
        • Denk H.
        Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis.
        J Hepatol. 2008; 48: 821-828
        • Michalak S.
        • Rousselet M.-C.
        • Bedossa P.
        • Pilette C.
        • Chappard D.
        • Oberti F.
        • et al.
        Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease.
        J Pathol. 2003; 201: 55-62
        • Sakhuja P.
        Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?.
        World J Gastroenterol. 2014; 20: 16474
        • Afifiyan N.
        • Tillman B.
        • French B.A.
        • Sweeny O.
        • Masouminia M.
        • Samadzadeh S.
        • et al.
        The role of Tec kinase signaling pathways in the development of Mallory Denk bodies in balloon cells in alcoholic hepatitis.
        Exp Mol Pathol. 2017; 103: 191-199
        • Uchida T.
        • Kronborg I.
        • Peters R.L.
        Giant mitochondria in the alcoholic liver diseases—their identification, frequency and pathologic significance.
        Liver. 1984; 4: 29-38
        • Kobyliak N.
        • Dynnyk O.
        • Abenavoli L.
        The role of liver biopsy to assess alcoholic liver disease.
        Rev Recent Clin Trials. 2016; 11: 175-179
        • Altamirano J.
        • Miquel R.
        • Katoonizadeh A.
        • Abraldes J.G.
        • Duarte-Rojo A.
        • Louvet A.
        • et al.
        A histologic scoring system for prognosis of patients with alcoholic hepatitis.
        Gastroenterology. 2014; 146: 1231-1239.e6
        • Naveau S.
        • Raynard B.
        • Ratziu V.
        • Abella A.
        • Imbert-Bismut F.
        • Messous D.
        • et al.
        Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.
        2005
        • Thiele M.
        • Madsen B.S.
        • Hansen J.F.
        • Detlefsen S.
        • Antonsen S.
        • Krag A.
        • et al.
        Accuracy of the enhanced liver fibrosis test vs fibrotest, elastography and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease.
        Gastroenterology. 2018; 154: 1369-1379
        • Calès P.
        • Oberti F.
        • Michalak S.
        • Hubert-Fouchard I.
        • Rousselet M.C.
        • Konaté A.
        • et al.
        A novel panel of blood markers to assess the degree of liver fibrosis.
        Hepatology. 2005; 42: 1373-1381
        • Huang Y.
        • Adams L.A.
        • Joseph J.
        • Bulsara M.K.
        • Jeffrey G.P.
        The ability of hepascore to predict liver fibrosis in chronic liver disease: a meta-analysis.
        Liver Int. 2017; 37: 121-131
        • Moreno C.
        • Mueller S.
        • Szabo G.
        Non-invasive diagnosis and biomarkers in alcohol-related liver disease.
        J Hepatol. 2019; 70: 273-283
        • Thabut D.
        • Naveau S.
        • Charlotte F.
        • Massard J.
        • Ratziu V.
        • Imbert-Bismut F.
        • et al.
        The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.
        J Hepatol. 2006; 44: 1175-1185
        • Maruzzelli L.
        • Parr A.J.
        • Miraglia R.
        • Tuzzolino F.
        • Luca A.
        Quantification of hepatic steatosis.
        Acad Radiol. 2014; 21: 507-513
        • Abenavoli L.
        • Corpechot C.
        • Poupon R.
        Elastography in hepatology.
        Can J Gastroenterol. 2007; 21: 839-842
        • Nguyen-Khac E.
        • Thiele M.
        • Voican C.
        • Nahon P.
        • Moreno C.
        • Boursier J.
        • et al.
        Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis.
        Lancet Gastroenterol Hepatol. 2018; 3: 614-625
        • Nahon P.
        • Kettaneh A.
        • Tengher-Barna I.
        • Ziol M.
        • de Lédinghen V.
        • Douvin C.
        • et al.
        Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
        J Hepatol. 2008; 49: 1062-1068
        • Voican C.S.
        • Louvet A.
        • Trabut J.-B.
        • Njiké-Nakseu M.
        • Dharancy S.
        • Sanchez A.
        • et al.
        Transient elastography alone and in combination with FibroTest® for the diagnosis of hepatic fibrosis in alcoholic liver disease.
        Liver Int. 2017; 37: 1697-1705
        • de Lédinghen V.
        • Vergniol J.
        • Capdepont M.
        • Chermak F.
        • Hiriart J.B.
        • Cassinotto C.
        • et al.
        Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.
        J Hepatol. 2014; 60: 1026-1031
        • Rosato V.
        • Abenavoli L.
        • Federico A.
        • Masarone M.
        • Persico M.
        Pharmacotherapy of alcoholic liver disease in clinical practice.
        Int J Clin Pract. 2016; 70: 119-131
        • Basra G.
        • Basra S.
        • Parupudi S.
        Symptoms and signs of acute alcoholic hepatitis.
        World J Hepatol. 2011; 3: 118
        • Rambaldi A.
        • Saconato H.H.
        • Christensen E.
        • Thorlund K.
        • Wetterslev J.
        • Gluud C.
        Systematic review: glucocorticosteroids for alcoholic hepatitis—a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials.
        Aliment Pharmacol Ther. 2008; 27: 1167-1178
        • Dunn W.
        • Jamil L.H.
        • Brown L.S.
        • Wiesner R.H.
        • Kim W.R.
        • Menon K.V.
        • et al.
        MELD accurately predicts mortality in patients with alcoholic hepatitis.
        Hepatology. 2005; 41: 353-358
        • Forrest E.H.
        • Morris A.J.
        • Stewart S.
        • Phillips M.
        • Oo Y.H.
        • Fisher N.C.
        • et al.
        The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids.
        Gut. 2007; 56: 1743-1746
        • Dominguez M.
        • Rincón D.
        • Abraldes J.G.
        • Miquel R.
        • Colmenero J.
        • Bellot P.
        • et al.
        A new scoring system for prognostic stratification of patients with alcoholic hepatitis.
        Am J Gastroenterol. 2008; 103: 2747-2756
        • Louvet A.
        • Naveau S.
        • Abdelnour M.
        • Ramond M.J.
        • Diaz E.
        • Fartoux L.
        • et al.
        The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
        Hepatology. 2007; 45: 1348-1354
        • Caballería J.
        • Parés A.
        • Brú C.
        • Mercader J.
        • García Plaza A.
        • Caballería L.
        • et al.
        Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver.
        J Hepatol. 1998; 28: 54-60
        • Vassallo G.
        • Mirijello A.
        • Ferrulli A.
        • Antonelli M.
        • Landolfi R.
        • Gasbarrini A.
        • et al.
        Review article: alcohol and gut microbiota—the possible role of gut microbiota modulation in the treatment of alcoholic liver disease.
        Aliment Pharmacol Ther. 2015; 41: 917-927
        • Sarin S.K.
        • Pande A.
        • Schnabl B.
        Microbiome as a therapeutic target in alcohol-related liver disease.
        J Hepatol. 2019; 70: 260-272
        • Singal A.K.
        • Charlton M.R.
        Nutrition in alcoholic liver disease.
        Clin Liver Dis. 2012; 16: 805-826
        • Louvet A.
        • Labreuche J.
        • Artru F.
        • Bouthors A.
        • Rolland B.
        • Saffers P.
        • et al.
        Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study.
        Hepatology. 2017; 66: 1464-1473
        • Addolorato G.
        • Mirijello A.
        • Barrio P.
        • Gual A.
        Treatment of alcohol use disorders in patients with alcoholic liver disease.
        J Hepatol. 2016; 65: 618-630
        • Addolorato G.
        • Vassallo G.A.
        • Mirijello A.
        • Gasbarrini A.
        Diagnosis and management of alcohol use disorder in patients with liver disease: lights and shadows.
        Neurotherapeutics. 2019; https://doi.org/10.1007/s13311-019-00802-8
        • Mirijello A.
        • D’Angelo C.
        • Ferrulli A.
        • Vassallo G.
        • Antonelli M.
        • Caputo F.
        • et al.
        Identification and management of alcohol withdrawal syndrome.
        Drugs. 2015; 75: 353-365
        • Addolorato G.
        • Leggio L.
        • Abenavoli L.
        • Agabio R.
        • Caputo F.
        • Capristo E.
        • et al.
        Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam.
        Am J Med. 2006; 119: 276.e13-276.e18
        • Anton R.F.
        • O’Malley S.S.
        • Ciraulo D.A.
        • Cisler R.A.
        • Couper D.
        • Donovan D.M.
        • et al.
        Combined pharmacotherapies and behavioral interventions for alcohol dependence.
        JAMA. 2006; 295: 2003
        • Antonelli M.
        • Ferrulli A.
        • Sestito L.
        • Vassallo G.A.
        • Tarli C.
        • Mosoni C.
        • et al.
        Alcohol addiction—the safety of available approved treatment options.
        Expert Opin Drug Saf. 2018; 17: 169-177
        • European Association for the Study of Liver
        EASL clinical practical guidelines: management of alcoholic liver disease.
        J Hepatol. 2012; 57: 399-420
        • Addolorato G.
        • Mirijello A.
        • Leggio L.
        • Ferrulli A.
        • Landolfi R.
        Management of alcohol dependence in patients with liver disease.
        CNS Drugs. 2013; 27: 287-299
        • Mann K.
        • Bladström A.
        • Torup L.
        • Gual A.
        • van den Brink W.
        Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
        Biol Psychiatry. 2013; 73: 706-713
        • Leone M.A.
        • Vigna-Taglianti F.
        • Avanzi G.
        • Brambilla R.
        • Faggiano F.
        Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
        Cochrane Database Syst Rev. 2010; CD006266
        • Addolorato G.
        • Leggio L.
        Safety and efficacy of baclofen in the treatment of alcohol-dependent patients.
        Curr Pharm Des. 2010; 16: 2113-2117
        • Agabio R.
        • Sinclair J.M.
        • Addolorato G.
        • Aubin H.J.
        • Beraha E.M.
        • Caputo F.
        • et al.
        Baclofen for the treatment of alcohol use disorder: the Cagliari statement.
        Lancet Psychiatry. 2018; 5: 957-960
        • Brower K.J.
        • Myra Kim H.
        • Strobbe S.
        • Karam-Hage M.A.
        • Consens F.
        • Zucker R.A.
        A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.
        Alcohol Clin Exp Res. 2008; 32: 1429-1438
        • Stein E.
        • Cruz-Lemini M.
        • Altamirano J.
        • Ndugga N.
        • Couper D.
        • Abraldes J.G.
        • et al.
        Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide.
        J Hepatol. 2016; 65: 998-1005
        • Mathurin P.
        • Bataller R.
        Trends in the management and burden of alcoholic liver disease.
        J Hepatol. 2015; 62: S38-S46
        • Khan A.
        • Tansel A.
        • White D.L.
        • Kayani W.T.
        • Bano S.
        • Lindsay J.
        • et al.
        Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review.
        Clin Gastroenterol Hepatol. 2016; 14: 191-202
        • Addolorato G.
        • Leggio L.
        • Ferrulli A.
        • Cardone S.
        • Vonghia L.
        • Mirijello A.
        • et al.
        Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.
        Lancet. 2007; 370: 1915-1922
        • Morley K.C.
        • Baillie A.
        • Fraser I.
        • Furneaux-Bate A.
        • Dore G.
        • Roberts M.
        • et al.
        Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial.
        Br J Psychiatry. 2018; 212: 362-369
        • Mosoni C.
        • Dionisi T.
        • Vassallo G.A.
        • Mirijello A.
        • Tarli C.
        • Antonelli M.
        • et al.
        Baclofen for the treatment of alcohol use disorder in patients with liver cirrhosis: 10 years after the first evidence.
        Front Psychiatry. 2018; 9: 474
        • Addolorato G.
        • Bataller R.
        • Burra P.
        • DiMartini A.
        • Graziadei I.
        • Lucey M.R.
        • et al.
        Liver transplantation for alcoholic liver disease.
        Transplantation. 2016; 100: 981-987
        • Burra P.
        • Belli L.S.
        • Ginanni Corradini S.
        • Volpes R.
        • Marzioni M.
        • Giannini E.
        • et al.
        Common issues in the management of patients in the waiting list and after liver transplantation.
        Dig Liver Dis. 2017; 49: 241-253
        • Addolorato G.
        • Mirijello A.
        • Leggio L.
        • Ferrulli A.
        • D'Angelo C.
        • Vassallo G.
        • et al.
        Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center.
        Alcohol Clin Exp Res. 2013; 37: 1601-1608
        • Mathurin P.
        • Moreno C.
        • Samuel D.
        • Dumortier J.
        • Salleron J.
        • Durand F.
        • et al.
        Early liver transplantation for severe alcoholic hepatitis.
        N Engl J Med. 2011; 365: 1790-1800
        • Im G.Y.
        • Kim-Schluger L.
        • Shenoy A.
        • Schubert E.
        • Goel A.
        • Friedman S.L.
        • et al.
        Early liver transplantation for severe alcoholic hepatitis in the United States—a single-center experience.
        Am J Transplant. 2016; 16: 841-849
        • Lee B.P.
        • Chen P.-H.
        • Haugen C.
        • Hernaez R.
        • Gurakar A.
        • Philosophe B.
        • et al.
        Three-year results of a pilot program in early liver transplantation for severe alcoholic hepatitis.
        Ann Surg. 2017; 265: 20-29
        • Lee B.P.
        • Mehta N.
        • Platt L.
        • Gurakar A.
        • Rice J.P.
        • Lucey M.R.
        • et al.
        Outcomes of early liver transplantation for patients with severe alcoholic hepatitis.
        Gastroenterology. 2018; 155: 422-430.e1
        • Weeks S.R.
        • Sun Z.
        • McCaul M.E.
        • Zhu H.
        • Anders R.A.
        • Philosophe B.
        • et al.
        Liver transplantation for severe alcoholic hepatitis, updated lessons from the world’s largest series.
        J Am Coll Surg. 2018; 226: 549-557
      8. Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment (QuickTrans) NCT01756794 2018.

        • Stroh G.
        • Rosell T.
        • Dong F.
        • Forster J.
        Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation.
        Am J Transplant. 2015; 15: 1598-1604
        • Thursz M.
        • Allison M.
        Liver transplantation for alcoholic hepatitis: being consistent about where to set the bar.
        Liver Transplant. 2018; 24: 733-734